Extensive Options for Graphene Quantum Dot Modifications

Pretreatment Chemicals Make Electroplating More Efficient

BRIM Biotechnology receives FDA agreement on Phase 3 clinical trial design for BRM421, BRIM’s lead candidate for Dry Eye Disease, at End of Phase 2 Meeting

BRIM Biotechnology, Inc. ("BRIM," TPEx 6885) is pleased to announce that it has received agreement from the US Food and Drug Administration (FDA) on the Phase 3 clinical trial design for its lead candidate for Dry Eye Disease (DED), BRM421, at the End of Phase 2 Meeting. BRIM will submit the Phase 3 study protocol to the FDA in Q4 2022.

Proscia Presents Study Results On New Artificial Intelligence That Predicts Diagnostic Concordance For Melanoma

Findings illustrate promise of technology to lower misdiagnosis rate for deadliest form of skin cancer

Creative Biogene Develops Custom Lentivirus Services to Support Stable Cell Line Generation

Microbiosci Releases LPS Extraction Service to Support Managing Endotoxins Issues

Nanoparticle Development Services for Drug Delivery System Research

Creative Biogene Delivers Knockout Mouse Models to Support Gene Editing and Future Studies

Acylation Reagents for Gas Chromatography and Other Instrumental Analytical Methods

ExoQuali Products and Protocols Released by Creative Bioarray to Easy Exosome Isolation Process

Histobiolab Provides Over 150 Fish Probes to Satisfy Precise Biological Research Needs

Creative Bioarray Provides 3D Cell Patterning Service Based to Speed up Drug Screening

PubHive Upgrades SaaS Platform to MedDRA Version 25.1

Drug safety and pharmacovigilance (DSPV) teams that license access to the PubHive Navigator platform can now access the newest MedDRA version when performing signal evaluation and reporting activities

Terumo Pharmaceutical Solutions expands CDMO services outside Japan for global market

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and manufacturing services for parenteral drugs to global customers.

MULTI-LEVEL & MULTI-ANALYTE LIQUID STABLE CLINICAL ENZYME CALIBRATION VERIFIERS AVAILABLE FROM VERICHEM

CARLSBAD, Calif. (Oct. 31, 2022) – Thermo Fisher Scientific introduces new dPCR wastewater surveillance kit and RNA master mix to simplify detection of SARS-CoV-2 targets

New NoriZite™ Nasal Spray launches in the UK

Birmingham Biotech LTD, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, today announces that NoriZite™ Nasal Spray, an easy-to-use nasal device designed to block and trap inhaled virus particles, is now available to buy in the UK.

Samsung Biologics Reports Third Quarter 2022 Financial Results

Samsung Biologics reports third quarter 2022 financial results

Abundent Application Potentials of Nanomaterials

Alfa Chemistry Announces Offering of Low Molecular Weight Carboxylic Acids